"We are very excited to study the effectiveness of nanoviricides against the most current strains of H5N1 in animal models,” said lead AFIP scientist Dr. Mina Izadjoo.
AFID = Armed Forces Institute of Pathology
Dr. Mina Izadjoo = Publications
H5N1 = Bird Flu
"Very Excited" = $80B = Market for the company that cures common influenza
NNVC = The Company is developing anti-influenza drugs under the brand names FluCide™, and FluCide-HP™. FluCide is a broad-spectrum nanoviricide that mimics sialic acid, and therefore no influenza viruses (including bird flu) can escape it, no matter how much they mutate, say the Company scientists. FluCide-HP is expected to be more effective against all highly pathogenic avian influenza (HPAI) viruses than is FluCide, according to the Company’s proprietary data. Any of the HPAI viruses may cause a potential pandemic, according to the World Health Organization (WHO). The most prevalent current HPAI virus is H5N1.
120MM = Outstanding Shares of NNVC
$80B/$120M = Hold these shares tightly